Aptinyx Inc.
APTXDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001674365
Aptinyx Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 32 institutions reported holding it in 13F filings for Q1 2023, worth $2.44M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Aptinyx Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 41 | 40 | −1 |
| Shares | 34.2M | 31.1M | −3.11M (−9.1%) |
| Value | $19.1M | $11.5M | −$7.61M (−39.9%) |
New holders (9)
Institutions that held Aptinyx Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 1,954,698 | $720.0K | 0.02% |
| HBK Sorce Advisory LLC | 26,000 | $26.0K | 0.00% |
| UBS Group AG | 27,395 | $10.0K | 0.00% |
| Virtu Financial LLC | 23,806 | $9.00K | 0.00% |
| Two Sigma Securities, LLC | 10,873 | $4.00K | 0.00% |
| HRT Financial LP | 13,083 | $4.00K | 0.00% |
| Bank of America Corp | 1,050 | $0 | 0.00% |
| Royal Bank of Canada | 432 | $0 | 0.00% |
| Allworth Financial LP | 1,000 | $0 | 0.00% |
Sold out (10)
Institutions that held Aptinyx Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1.84M |
| OrbiMed Advisors LLC | 538,500 | $300.0K |
| JPMorgan Chase & Co | 263,954 | $147.0K |
| DCF Advisers, LLC | 48,529 | $27.0K |
| HSBC Holdings PLC | 37,152 | $20.0K |
| Ameriprise Financial Inc | 13,200 | $7.00K |
| Goldman Sachs Group Inc | 12,342 | $7.00K |
| Tower Research Capital LLC (TRC) | 5,772 | $3.00K |
| Advisor Group Holdings, Inc. | 1,000 | $1.00K |
| Simplex Trading, LLC | 200 | $0 |